Survival in Pulmonary Hypertension Registries: The Importance of Incident Cases
暂无分享,去创建一个
[1] Dave P. Miller,et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. , 2010, Chest.
[2] Christopher S Coffey,et al. Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.
[3] L. Chawla,et al. Femoral-based central venous oxygen saturation is not a reliable substitute for subclavian/internal jugular-based central venous oxygen saturation in patients who are critically ill. , 2010, Chest.
[4] M. Humbert,et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.
[5] P. Corris,et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. , 2009, American journal of respiratory and critical care medicine.
[6] P. Corris,et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.
[7] L. Chawla,et al. Lack of equivalence between central and mixed venous oxygen saturation. , 2004, Chest.
[8] R. V. van Lingen,et al. Venous oxygen measurements in the inferior vena cava in neonates with respiratory failure , 1998, Critical care.
[9] A. Aberman,et al. Mixed venous oxygen saturation. Its role in the assessment of the critically ill patient. , 1983, Archives of internal medicine.